Jennifer K. Simpson - Net Worth and Insider Trading

Jennifer K. Simpson Net Worth

The estimated net worth of Jennifer K. Simpson is at least $221 dollars as of 2024-04-25. Jennifer K. Simpson is the President and CEO of Panbela Therapeutics Inc and owns about 393 shares of Panbela Therapeutics Inc (PBLA) stock worth over $161. Jennifer K. Simpson is also the President & CEO of Delcath Systems Inc and owns about 11 shares of Delcath Systems Inc (DCTH) stock worth over $60. Details can be seen in Jennifer K. Simpson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jennifer K. Simpson has not made any transactions after 2023-01-30 and currently still holds the listed stock(s).

Transaction Summary of Jennifer K. Simpson

To

Jennifer K. Simpson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jennifer K. Simpson owns 4 companies in total, including Panbela Therapeutics Inc (PBLA) , Delcath Systems Inc (DCTH) , and Eagle Pharmaceuticals Inc (EGRX) among others .

Click here to see the complete history of Jennifer K. Simpson’s form 4 insider trades.

Insider Ownership Summary of Jennifer K. Simpson

Ticker Comapny Transaction Date Type of Owner
PBLA Panbela Therapeutics Inc 2023-01-30 director & President and CEO
DCTH Delcath Systems Inc 2018-09-28 President & CEO
EGRX Eagle Pharmaceuticals Inc 2019-08-28 director
LADX LadRx Corp 2021-07-29 director

Jennifer K. Simpson Latest Holdings Summary

Jennifer K. Simpson currently owns a total of 2 stocks. Among these stocks, Jennifer K. Simpson owns 393 shares of Panbela Therapeutics Inc (PBLA) as of January 30, 2023, with a value of $161 and a weighting of 72.89%. Jennifer K. Simpson also owns 11 shares of Delcath Systems Inc (DCTH) as of September 28, 2018, with a value of $60 and a weighting of 27.11%.

Latest Holdings of Jennifer K. Simpson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PBLA Panbela Therapeutics Inc 2023-01-30 393 0.41 161
DCTH Delcath Systems Inc 2018-09-28 11 5.45 60

Holding Weightings of Jennifer K. Simpson


Jennifer K. Simpson Form 4 Trading Tracker

According to the SEC Form 4 filings, Jennifer K. Simpson has made a total of 2 transactions in Panbela Therapeutics Inc (PBLA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Panbela Therapeutics Inc is the acquisition of 222 shares on January 30, 2023, which cost Jennifer K. Simpson around $6,799.

According to the SEC Form 4 filings, Jennifer K. Simpson has made a total of 0 transactions in Delcath Systems Inc (DCTH) over the past 5 years. The most-recent trade in Delcath Systems Inc is the acquisition of 11 shares on September 28, 2018, which cost Jennifer K. Simpson around $12,948.

Insider Trading History of Jennifer K. Simpson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jennifer K. Simpson Trading Performance

GuruFocus tracks the stock performance after each of Jennifer K. Simpson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennifer K. Simpson is -42.65%. GuruFocus also compares Jennifer K. Simpson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennifer K. Simpson within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jennifer K. Simpson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jennifer K. Simpson

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -30.11 -42.65 -54.44 -76.76 -80.04 -84.92
Relative Return to S&P 500(%) -29.48 -41.45 -60.3 -92.66 -88.5 -98.39

Jennifer K. Simpson Ownership Network

Ownership Network List of Jennifer K. Simpson

No Data

Ownership Network Relation of Jennifer K. Simpson


Jennifer K. Simpson Owned Company Details

What does Panbela Therapeutics Inc do?

Who are the key executives at Panbela Therapeutics Inc?

Jennifer K. Simpson is the director & President and CEO of Panbela Therapeutics Inc. Other key executives at Panbela Therapeutics Inc include V.P. of Finance & CFO Susan Horvath , 10 percent owner Ryan Randall Gilbertson , and 10 percent owner Ryan R. Gilbertson 2012 Irrevocable Trust .

Panbela Therapeutics Inc (PBLA) Insider Trades Summary

Over the past 18 months, Jennifer K. Simpson made 1 insider transaction in Panbela Therapeutics Inc (PBLA) with a net purchase of 4,444. Other recent insider transactions involving Panbela Therapeutics Inc (PBLA) include a net sale of 72,874 shares made by Goldman Sachs Group Inc , a net purchase of 4,444 shares made by Susan Horvath ,

In summary, during the past 3 months, insiders sold 0 shares of Panbela Therapeutics Inc (PBLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,644 shares of Panbela Therapeutics Inc (PBLA) were sold and 444 shares were bought by its insiders, resulting in a net sale of 3,199 shares.

Panbela Therapeutics Inc (PBLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Panbela Therapeutics Inc Insider Transactions

No Available Data

Jennifer K. Simpson Mailing Address

Above is the net worth, insider trading, and ownership report for Jennifer K. Simpson. You might contact Jennifer K. Simpson via mailing address: C/o Delcath Systems, Inc., 810 Seventh Avenue, Suite 3505, New York Ny 10019.

Discussions on Jennifer K. Simpson

No discussions yet.